ChromaDex launches ‘clinical strength’ Tru Niagen Pro

02-Nov-2023 - Last updated on 02-Nov-2023 at 16:18 GMT

By boosting NAD, nicotinamide riboside may increase mitochondrial health and induce the creation of new mitochondria – the powerhouses of our cells. Image © CIPhotos / Getty Images

California-based ChromaDex Corp. has launched a high dose Tru Niagen product containing 1,000 mg of its Nicotinamide Riboside ingredient.

Over half of all the published clinical studies of Niagen have used the 1,000mg dose, said the company, with such a dose reported to boost NAD+ levels by up to 150% in as little as three weeks.

Tru Niagen Pro 1,000mg is recommended by physicians and used by pro-athletes, said ChromaDex. The product is Certified for Sport by NSF International, the only third-party certification program recognized by the United States Anti-Doping Agency (USADA), Major League Baseball (MLB), and the National Hockey League (NHL).

“Research indicates that NAD+ decreases with age and, more specifically, that NAD+ levels are depressed in organs facing metabolic stress and age-related functional decline,” said Dr. Andrew Shao, Senior Vice President of Global Regulatory & Scientific Affairs, ChromaDex. “1,000 mg is the most well-researched daily Niagen serving in published human studies, the results of which consistently demonstrate that elevated NAD+ levels correspond to a range of healthy aging benefits, including lowering age-related inflammation.”

NR

In 2004, Dr Charles Brenner discovered that nicotinamide riboside (NR) is a potent precursor to nicotinamide adenine dinucleotide (NAD). NAD is an important cellular co-factor for improvement of mitochondrial performance and energy metabolism.

As organisms age, NAD levels drop, which leads to a decrease in mitochondrial health; this in turn leads to age-related health issues. By boosting NAD, NR may increase mitochondrial health and induce the creation of new mitochondria.

Niagen, ChromaDex’s branded nicotinamide riboside, has been shown to increase NAD+ levels safely and efficaciously in numerous published human trials.

Niagen is supported by two successful NDI notifications (NDIN 882 in 2015 and NDIN 1062 in 2018), as well as a successful GRAS notification (GRN 635). ChromaDex states that published clinical studies indicate that the ingredient is safe to take up to 2,000mg per day.

The ChromaDex External Research Program (CERPTM) reached over 250 material transfer agreements (MTAs) featuring Niagen and other proprietary ingredients.

Unveiling

Tru Niagen Pro 1,000mg was unveiled to a select group of Key Opinion Leaders (KOLs), physicians, influencers and celebrities at the Tru Niagen Wellness Retreat in Malibu last week.

“On behalf of the ChromaDex family, we are proud to bring the clinical-strength benefits of our profound NAD+ boosting Tru Niagen to individuals across the nation,” said Rob Fried, CEO of ChromaDex. “As a pioneer of NAD+ research, our team works with esteemed investigators across the globe to uncover the full potential of NAD+. When using 1,000mg or more of Tru Niagen, researchers have discovered pronounced benefits in numerous age-related conditions.”